Search Results 2671-2680 of 16196 for chemoprevention

  1. A Study to Evaluate MUC1 Vaccine to Prevent Lung Cancer in Current and Former Smokers at High Risk for Lung Cancer - Mayo Clinic

    The purpose of this study is to evaluate immunogenicity of the vaccine, assessed at week 12, based on the increase in IgG anti-MUC1 antibody titer over the pre- ...

  2. I have Medicaid or a managed Medicaid product — Cancer Patients Only - Mayo Clinic

    Because Medicaid requires little to no insurance premium or out of pocket, traditional copay and grant assistance programs are limited. However, it is important ...

  3. hTERT Immunotherapy Alone or in Combination With IL-12 DNA Followed by Electroporation in Adults With Solid Tumors at High Risk of Relapse - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  4. Stacy M. Peterson and Brooke L. Werneburg - Mayo Clinic

    Thanks to generous benefactors, your gift today can have 5X the impact to advance AI innovation at Mayo Clinic. Give Today · Find a doctor · Explore careers.

  5. A Study of Nulojix® (Belatacept) as Maintenance Immunosuppression in Kidney Transplant Recipients - Mayo Clinic

    The primary purpose of this study is to assess the benefits and risks of changing from Cyclosporine or Tacrolimus to Belatacept between 6-60 months after kidney ...

  6. Clinical Trials - Mayo Clinic Research

    Title: NRG-GY012, A Randomized Phase II Study Comparing Single-Agent Olaparib, Single Agent Cediranib, and the Combinations of Cediranib/Olaparib, ...

  7. A Study of Rifampicin in Multiple System Atrophy - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  8. SULF1 and SULF2 Role in Cholangiocarcinoma - Mayo Clinic

    Cholangiocarcinoma (CCA) has key similarities with HCC, therefore, we hypothesize that Sulf1 and Sulf2 may also play roles in promotion of CCA progression.

  9. A Study of SC‑004 in Subjects With Advanced Solid Tumors - Mayo Clinic

    Part A (dose regimen finding) will allow definition of the maximum tolerated dose (MTD) through dose escalation and possible dose interval modification. In Part ...

  10. A Study to Evaluate Sex Differences in Multiple Sclerosis Spectrum of Demyelinating Disorders - Mayo Clinic

    About this study. The purposes of this study are to explore the association between female sex, reproductive history and clinical phenotypic variability in ...